10/03/2026 20:11
|
Medical, Health & Aged Care
* Ferring's total revenues for 2025 exceeded €2.5 billion, an increase of 10% from 2024, mainly driven by our flagship product Menopur®
* Continued ramp-up in the US for Adstiladrin®, our novel...